| __timestamp | Arrowhead Pharmaceuticals, Inc. | Sanofi |
|---|---|---|
| Wednesday, January 1, 2014 | 24419536 | 8565000000 |
| Thursday, January 1, 2015 | 34718089 | 9496000000 |
| Friday, January 1, 2016 | 40998209 | 9592000000 |
| Sunday, January 1, 2017 | 32022880 | 10164000000 |
| Monday, January 1, 2018 | 19110051 | 9934000000 |
| Tuesday, January 1, 2019 | 26556257 | 9883000000 |
| Wednesday, January 1, 2020 | 52275890 | 9390000000 |
| Friday, January 1, 2021 | 80981000 | 9555000000 |
| Saturday, January 1, 2022 | 124431000 | 10539000000 |
| Sunday, January 1, 2023 | 90932000 | 10765000000 |
| Monday, January 1, 2024 | 98761000 | 9183000000 |
Cracking the code
In the ever-evolving pharmaceutical industry, understanding spending patterns is crucial for strategic growth. Sanofi, a global leader, and Arrowhead Pharmaceuticals, Inc., a rising star, present a fascinating study in contrasts. From 2014 to 2023, Sanofi's Selling, General, and Administrative (SG&A) expenses have consistently hovered around the $10 billion mark, reflecting its expansive global operations. In contrast, Arrowhead's SG&A expenses have shown a dynamic growth trajectory, increasing by over 300% from 2014 to 2023. This surge underscores Arrowhead's aggressive expansion and investment in innovation. Notably, 2022 marked a peak for Arrowhead, with expenses reaching approximately 12% of Sanofi's. However, 2024 data for Sanofi is missing, leaving room for speculation on future trends. This comparison not only highlights the scale of operations but also the strategic priorities of these pharmaceutical giants.
Operational Costs Compared: SG&A Analysis of Sanofi and Alkermes plc
Cost Management Insights: SG&A Expenses for Sanofi and Rhythm Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Sanofi and ADMA Biologics, Inc.
Who Optimizes SG&A Costs Better? Sanofi or Viridian Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Sanofi and MiMedx Group, Inc.
Vertex Pharmaceuticals Incorporated or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: GSK plc vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: SG&A Expense Trends
Dr. Reddy's Laboratories Limited and Arrowhead Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Amneal Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Arrowhead Pharmaceuticals, Inc. or Novavax, Inc.
SG&A Efficiency Analysis: Comparing Arrowhead Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.